GGrantIndex
Sort

23,748 grants matching melanoma

ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES

$280,157
University Of Arizona · R01 · FY2004 · CA

ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES

$280,157
University Of Arizona · R01 · FY2002 · CA

ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES

$280,157
University Of Arizona · R01 · FY2001 · CA

ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES

$280,157
University Of Arizona · R01 · FY2005 · CA

Epidemiologic Parameters of Rare Cancer Risk Factors

$280,131
Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA

Anti-GD3 NKT cells as effector cells against melanoma

$280,131
Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA

Anti-GD3 NKT cells as effector cells against melanoma

$280,131
Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · CA

Epidemiologic Parameters of Rare Cancer Risk Factors

$280,131
Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · CA

Therapy for Liver Cancer by Targeting Energy Metabolism

$279,965
Johns Hopkins University · R01 · FY2005 · CA

The role of the tumor biofilm in determining tissue tropism

$279,873
Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Ultrastaging of Early Colon Cancer

$279,828
Anton J Bilchik · University Of California Los Angeles · R01 · FY2010 · CA

IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES

$279,815
Jerry Niederkorn · Ut Southwestern Medical Center · R01 · FY2006 · CA

Cell-cell communication during melanoma development

$279,784
Meenhard Herlyn · Wistar Institute · R01 · FY2011 · CA

Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma.

$279,772
Sattva S Neelapu · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA

MDA-7/IL-24: Therapy of Prostate Cancer

$279,685
Paul B Fisher · Columbia University Health Sciences · P01 · FY2006 · CA

Manipulation of Tumor Specific Immunity

$279,675
Hans Schreiber · University Of Chicago · R01 · FY2019 · CA

PROSPECTIVE STUDY OF DIET AND CANCER IN MEN (HEALTH PROFESSIONALS FOLLOWUP)

$279,549
Harvard University (Medical School) · P01 · FY2000 · CA

TCR Transduced CD8+ T Cells for Adoptive Immunotherapy

$279,522
David J Cole · Loyola University Chicago · P01 · FY2012 · CA

THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY

$279,400
Rongfu Wang · Baylor College Of Medicine · P01 · FY2010 · CA

Tumorigenic moisturizing creams: mechanisms and active constituents

$279,348
Allan H Conney · Rutgers, The State Univ Of N.J. · R01 · FY2012 · CA

CHIMERIC T CELLS TARGETING NEUROBLASTOMA

$279,346
Malcolm K Brenner · Baylor College Of Medicine · P01 · FY2010 · CA

PET IMAGING OF MART TCR-ENGINEERED CD8 T CELL IMMUNOTHERAPY IN MAN

$279,344
James S. Economou · University Of California Los Angeles · R01 · FY2007 · CA

Mechanism of Eliciting Antitumor Cell Immunity Via Lentivector Immunization

$279,300
Yukai He · Augusta University · R01 · FY2008 · CA

Mechanism of Eliciting Antitumor Cell Immunity Via Lentivector Immunization

$279,300
Yukai He · Augusta University · R01 · FY2009 · CA

Mechanism of Eliciting Antitumor Cell Immunity Via Lentivector Immunization

$279,300
Yukai He · Augusta University · R01 · FY2010 · CA